Early Detection of Ovarian Cancer Using Uterine Lavage and Duplex Sequencing

Williams, Lindsey N.; Salk, Jesse J.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Small Business Innovation Research Grants (SBIR) - Phase II (R44)
• Project #: 5R44CA221426-03
• Application #: 9785423
• Study Section: Special Emphasis Panel (ZRG1)
• Program Officer: Evans, Gregory
• Project Start: 2018-09-14
• Project End: 2021-02-28
• Budget Start: 2019-09-01
• Budget End: 2020-08-31
• Support Year: 3
• Fiscal Year: 2019

Institution

• Name: Twinstrand Biosciences, Inc.
• DUNS #: 080451837
• City: Seattle
• State: WA
• Country: United States
• Zip Code: 98121

Publications

Nachmanson, Daniela; Lian, Shenyi; Schmidt, Elizabeth K et al. (2018) Targeted genome fragmentation with CRISPR/Cas9 enables fast and efficient enrichment of small genomic regions and ultra-accurate sequencing with low DNA input (CRISPR-DS). Genome Res 28:1589-1599

Risques, Rosa Ana; Kennedy, Scott R (2018) Aging and the rise of somatic cancer-associated mutations in normal tissues. PLoS Genet 14:e1007108